Evelo Biosciences Inc. (EVLO)
0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:00 PM
0.32
12536.00%
After-hours: Dec 11, 2023, 06:46 PM EST
No 1D chart data available
| Bid | 0.3 |
| Market Cap | 47.46K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -498.81M |
| EPS (ttm) | -15.64 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.3 |
| Volume | 1 |
| Avg. Volume (20D) | 4,803 |
| Open | 0.04 |
| Previous Close | 0.00 |
| Day's Range | 0.00 - 0.04 |
| 52-Week Range | 0.00 - 0.07 |
| Beta | 1.56 |
About EVLO
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated in...
Industry Biotechnology
Sector Healthcare
IPO Date May 8, 2018
Employees 66
Stock Exchange NASDAQ
Ticker Symbol EVLO
Website https://www.evelobio.com
3 months ago · businesswire.com
EVLO to Provide Dominion Energy With Safety Enhanced Energy Storage SystemsMONTRÉAL--(BUSINESS WIRE)--EVLO Energy Storage Inc. (EVLO), a fully integrated battery energy storage systems (BESS) provider and wholly owned subsidiary of Hydro-Québec, announces a major achievement...